Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > Looks good to me
View:
Post by Mike420life on Dec 04, 2020 8:22am

Looks good to me

Lookin like it's setting up for a run , 60 million shares gobbled up in the last 3 days ? What do they know?
Comment by reap37 on Dec 04, 2020 9:41am
That this technology is life changing and they are showing very promising results. The Aspire lawsuit was simply a roadblock from getting this therapy to market. I don't know if you guys realize that Kyle Makofka (Apsire CEO) was also Hemostemix's CEO at one point. So he had the insider scoop and obviously knows the potential results/revenue this can bring...
Comment by Stockmoneyman17 on Dec 05, 2020 9:30am
Also look up Jed wood. He was a director for Hemo back in 2016, same time as Kyle Makofka You think these boys don't no anything about the product Hemo has? This was the group who tried to take it over  IMO 
Comment by TriumphSpitSix on Dec 05, 2020 12:25pm
That's my reading as well. Makofka is a "finance bro" dºuchebag who smelled blood in the water when he brought in the Jed Wood vulture capital gang as his financial backers for the "restructuring" of Hemostemix. This cabal of sharks consists of Wood, Makofka, Drive Capital, JMWI and Jed Woods' own children Blake and Randi Wood, each with their own shell companies ...more  
Comment by milstogo on Dec 05, 2020 1:09pm
Exactly. I'm thinking Jeb Wood might be the one Kyle Makofka's talking about in that interview from September 2019. https://bioinformant.com/hemostemix/ When he starts out saying:  "I first became involved with Hemostemix when a longtime friend and business partner came to me with some concerns around an investment his Family Office had made in the company. He has a long ...more  
Comment by TriumphSpitSix on Dec 05, 2020 1:52pm
Ok, so it looks like I may have had causality backwards. It's Jed Woods who is the shark and had a pre-existing financial relationship with HEM. Looks like he brought Makofka in as his "tool" to restructure the company out of public existence and into his private control.
Comment by milstogo on Dec 05, 2020 5:23pm
That's what it looks like. Then Makofka counldn't resist the opportunity to climb on board with Wood and fleece the very company he's CEO of. IMO what a couple of slimballs if that's what it is. At the very least one would think it'd be a conflict of interest.  One thing we do know for sure though; if those two wanted the company that badly and went to such lengths ...more